These findings are consistent with previous studies that have elucidated the suppression of the IFN-I activation pathway by SARS-CoV-2, resulting in reduced levels of IFN-α and -β among COVID-19 patients [75,76,77]. Here, IFNA1 is linked to COVID-19.